Atlas Trials

Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)

Clinical trial NCT03477643 · COMPLETED

Trial details

NCT number
NCT03477643
Sponsor
PETHEMA Foundation
Status
COMPLETED
Study type
OBSERVATIONAL
Relapsed and Refractory Multiple Myeloma
Start date
2018-04-27
Primary completion
2020-07-14
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.